MENU
Showcases Stock ranks Forex

Teva Pharmaceutical Industries Ltd ADR (TEVA)
11.03  0.34 (3.18%) 08-08 16:00
Open: 10.86 Pre. Close: 10.69
High: 11.05 Low: 10.805
Volume: 20,185,751 Market Cap: 12,249M
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 11.057 - 11.089 11.089 - 11.126
Low: 10.71 - 10.75 10.75 - 10.795
Close: 10.959 - 11.02 11.02 - 11.088
Stock Technical Analysis
Overall:     
Target: Six months: 12.91
One year: 15.07
Support: Support1: 8.41
Support2: 6.78
Resistance: Resistance1: 11.05
Resistance2: 12.91
Pivot: 8.81
Moving Averages: MA(5): 10.33
MA(20): 8.36
MA(100): 8.54
MA(250): 8.71
MACD: MACD(12,26): 0.77
Signal(12,26,9): 0.42
%K %D: %K(14,3): 99.09
%D(3): 98.45
RSI: RSI(14): 81.97
52-Week: High: 11.05
Low: 6.78
Change(%): 13.2
Average Vol(K): 3-Month: 13355
10-Days: 25756
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

[ TEVA ] has closed below upper band by 10.6%. Bollinger Bands are 168.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
Stock chart
Stock News
Wed, 27 Jul 2022
Healthcare Stocks Moving Up and Down Wednesday: BWV, TEVA, CMRA, SNPX, SAVA, BJDX, BFRI, NCNA - InvestorsObserver

Wed, 27 Jul 2022
Pre-Open Movers: Alphabet, Microsoft Gain Post Earnings By Investing.com - Investing.com

Wed, 27 Jul 2022
$4.4 Billion Opioid Settlement Gives Teva Stock a Boost - Barron's

Thu, 07 Jul 2022
Is Teva Pharmaceutical Industries Ltd (TEVA) a Leader in the Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver

Tue, 07 Jun 2022
TEVA: 3 Top-Rated Israeli Stocks to Add to Your Watchlist - StockNews.com

Mon, 16 May 2022
TEVA: Teva Pharmaceutical Industries: Why Investors Should Buy the Dip - StockNews.com

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 1100.00
Shares Float (M) 1100.00
% Held by Insiders 1.50
% Held by Institutions 46.25
Shares Short (K) 17760
Shares Short Prior Month (K) 19380
Stock Financials
EPS 0.660
Book Value (p.s.) 9.490
Profit Margin -6.83
Operating Margin 18.87
Return on Assets (ttm) 3.8
Return on Equity (ttm) -10.0
Qtrly Rev. Growth -3.2
Gross Profit (p.s.) 6.900
Sales Per Share 14.027
EBITDA (p.s.) 3.855
Qtrly Earnings Growth
Operating Cash Flow (M) 1060.00
Levered Free Cash Flow (M) 2540.00
Stock Valuation
PE Ratio 16.71
PEG Ratio
Price to Book value 1.16
Price to Sales 0.79
Price to Cash Flow 11.45
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android